Market Closed -
Hong Kong S.E.
04:09:00 2024-05-03 EDT
|
5-day change
|
1st Jan Change
|
19.62
HKD
|
+1.03%
|
|
-8.96%
|
-4.06%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
75,452
|
49,504
|
43,125
|
54,681
|
58,004
|
56,723
|
-
|
-
|
Enterprise Value (EV)
1 |
91,399
|
63,204
|
63,166
|
64,207
|
58,004
|
68,215
|
66,080
|
64,608
|
P/E ratio
|
12.1
x
|
6.87
x
|
5.55
x
|
6.42
x
|
6.41
x
|
5.89
x
|
5.36
x
|
4.9
x
|
Yield
|
2.36%
|
4.35%
|
5.43%
|
4.68%
|
-
|
5.14%
|
5.65%
|
6.09%
|
Capitalization / Revenue
|
0.18
x
|
0.11
x
|
0.08
x
|
0.1
x
|
0.1
x
|
0.09
x
|
0.08
x
|
0.07
x
|
EV / Revenue
|
0.21
x
|
0.14
x
|
0.12
x
|
0.12
x
|
0.1
x
|
0.11
x
|
0.09
x
|
0.08
x
|
EV / EBITDA
|
5.09
x
|
3.21
x
|
2.67
x
|
2.59
x
|
2.35
x
|
2.6
x
|
2.31
x
|
2.08
x
|
EV / FCF
|
6.57
x
|
-13.8
x
|
9.72
x
|
3.47
x
|
-
|
14.3
x
|
6.99
x
|
6.91
x
|
FCF Yield
|
15.2%
|
-7.24%
|
10.3%
|
28.8%
|
-
|
6.99%
|
14.3%
|
14.5%
|
Price to Book
|
1.59
x
|
0.88
x
|
0.7
x
|
0.8
x
|
-
|
0.68
x
|
0.61
x
|
0.55
x
|
Nbr of stocks (in thousands)
|
2,967,629
|
3,118,654
|
3,120,656
|
3,120,656
|
3,120,656
|
3,120,656
|
-
|
-
|
Reference price
2 |
25.42
|
15.87
|
13.82
|
17.52
|
18.59
|
18.18
|
18.18
|
18.18
|
Announcement Date
|
20-03-30
|
21-03-21
|
22-03-20
|
23-03-26
|
24-03-24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
425,273
|
456,415
|
521,051
|
552,148
|
596,570
|
648,904
|
706,787
|
767,575
|
EBITDA
1 |
17,950
|
19,667
|
23,634
|
24,769
|
24,639
|
26,207
|
28,646
|
31,120
|
EBIT
1 |
16,137
|
17,760
|
19,712
|
20,604
|
20,209
|
23,122
|
25,297
|
27,636
|
Operating Margin
|
3.79%
|
3.89%
|
3.78%
|
3.73%
|
3.39%
|
3.56%
|
3.58%
|
3.6%
|
Earnings before Tax (EBT)
1 |
13,760
|
15,598
|
17,003
|
18,564
|
19,512
|
20,803
|
22,914
|
25,070
|
Net income
1 |
6,253
|
7,187
|
7,759
|
8,526
|
9,054
|
9,612
|
10,583
|
11,587
|
Net margin
|
1.47%
|
1.57%
|
1.49%
|
1.54%
|
1.52%
|
1.48%
|
1.5%
|
1.51%
|
EPS
2 |
2.100
|
2.310
|
2.490
|
2.730
|
2.900
|
3.084
|
3.392
|
3.711
|
Free Cash Flow
1 |
13,909
|
-4,574
|
6,501
|
18,481
|
-
|
4,771
|
9,453
|
9,355
|
FCF margin
|
3.27%
|
-1%
|
1.25%
|
3.35%
|
-
|
0.74%
|
1.34%
|
1.22%
|
FCF Conversion (EBITDA)
|
77.49%
|
-
|
27.51%
|
74.61%
|
-
|
18.21%
|
33%
|
30.06%
|
FCF Conversion (Net income)
|
222.46%
|
-
|
83.79%
|
216.77%
|
-
|
49.64%
|
89.32%
|
80.74%
|
Dividend per Share
2 |
0.6000
|
0.6900
|
0.7500
|
0.8200
|
-
|
0.9338
|
1.027
|
1.106
|
Announcement Date
|
20-03-30
|
21-03-21
|
22-03-20
|
23-03-26
|
24-03-24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
223,608
|
203,765
|
252,650
|
249,120
|
271,931
|
261,472
|
290,676
|
18,687
|
155,433
|
300,950
|
144,969
|
150,650
|
295,619
|
311,580
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
8,772
|
10,940
|
9,057
|
11,547
|
-
|
5,895
|
10,869
|
5,937
|
4,691
|
10,628
|
10,518
|
Operating Margin
|
-
|
-
|
-
|
3.52%
|
4.02%
|
3.46%
|
3.97%
|
-
|
3.79%
|
3.61%
|
4.1%
|
3.11%
|
3.6%
|
3.38%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
5,228
|
8,866
|
4,161
|
6,485
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
362.2
|
2,514
|
4,104
|
1,752
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.94%
|
1.62%
|
1.36%
|
1.21%
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-30
|
20-08-23
|
21-03-21
|
21-08-22
|
22-03-20
|
22-08-29
|
23-03-26
|
23-04-17
|
23-08-27
|
23-08-27
|
23-10-30
|
24-03-24
|
24-03-24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,947
|
13,699
|
20,041
|
9,526
|
-
|
11,492
|
9,357
|
7,885
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8884
x
|
0.6966
x
|
0.848
x
|
0.3846
x
|
-
|
0.4385
x
|
0.3266
x
|
0.2534
x
|
Free Cash Flow
1 |
13,909
|
-4,574
|
6,501
|
18,481
|
-
|
4,771
|
9,453
|
9,355
|
ROE (net income / shareholders' equity)
|
13.9%
|
13.9%
|
13.1%
|
13.1%
|
-
|
11.8%
|
11.9%
|
11.4%
|
ROA (Net income/ Total Assets)
|
2.47%
|
2.47%
|
2.4%
|
2.44%
|
-
|
2.38%
|
2.42%
|
2.41%
|
Assets
1 |
252,832
|
290,559
|
323,331
|
350,101
|
-
|
404,346
|
438,073
|
481,103
|
Book Value Per Share
2 |
16.00
|
18.10
|
19.80
|
21.80
|
-
|
26.70
|
29.70
|
33.20
|
Cash Flow per Share
2 |
6.320
|
3.590
|
2.980
|
6.720
|
-
|
6.040
|
3.430
|
6.080
|
Capex
1 |
4,868
|
4,585
|
2,807
|
2,482
|
-
|
3,320
|
3,164
|
3,296
|
Capex / Sales
|
1.14%
|
1%
|
0.54%
|
0.45%
|
-
|
0.51%
|
0.45%
|
0.43%
|
Announcement Date
|
20-03-30
|
21-03-21
|
22-03-20
|
23-03-26
|
24-03-24
|
-
|
-
|
-
|
Last Close Price
18.18
CNY Average target price
24.61
CNY Spread / Average Target +35.40% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.06% | 7.84B | | +14.23% | 69.5B | | +7.11% | 8.2B | | -20.55% | 7.97B | | +2.26% | 4.66B | | +17.12% | 4.32B | | +1.41% | 4.19B | | -3.02% | 3.89B | | +21.42% | 3.62B | | +8.64% | 3.41B |
Pharmaceuticals Wholesale
|